This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) in the amount of $2,210,409 is aimed at examining ways to align the historically misaligned incentives created by the Medicare and Medicaid programs in nursing homes. The overall objective is to improve care and outcomes for nursing home residents with Alzheimer's disease and related dementias (AD/ADRD), who make up over one million of the total nursing home population. The award supports...
This $3,732,394 federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will support a 5-year cluster randomized trial to evaluate the effectiveness of the Palliative Care Education in Assisted Living for Dementia Care Providers (PCEAL-DCP) intervention. The PCEAL-DCP aims to improve dementia care quality outcomes, including increased documentation of advance care planning discussions and higher hospice admission rates, at 30 assisted living facilities....
This federal Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) totaling $671,042 will fund a 5-year research project at the University of Pennsylvania to study the impact of economic policies on the dementia care workforce and patient outcomes. The key objectives are to analyze how changes in minimum wages, staffing regulations, and unionization affect wages, turnover, and poverty among home health and nursing home workers, and how these workforce...
This $2,278,636 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will support research to characterize and evaluate different care models used by physicians and advanced practitioners, primarily nurse practitioners, who provide general medical care to nursing home residents with Alzheimer's disease and related dementias (ADRD). The goal is to understand the characteristics and outcomes of existing clinician care models in order to inform policy and practice...
This federal Project Grant award, provided by the National Institute on Aging under CFDA program 93.866 (Aging Research), aims to leverage data from the Dementia Care Study (D-CARE) to examine end-of-life care outcomes for community-dwelling persons living with dementia (PLWD). The $2,303,477 award, effective September 1, 2024, will support the following key activities: Comparison of advance care preference documentation and content between the Health System-based Dementia Care (HSDC) and...
This $334,788 Project Grant awarded by the National Institute on Aging (CFDA 93.866 - Aging Research) aims to investigate the impact of recent revisions to the Medicare home health payment system (Patient-Driven Groupings Model or PDGM) on access, care delivery, and outcomes for community-living Medicare beneficiaries with Alzheimer's disease and related dementias (ADRD). The 2-year study, starting September 1, 2023, will leverage Medicare claims, home health assessment, and agency data to:...
The National Institute on Aging (NIA) awarded a $1.193M Project Grant (CFDA 93.866 - Aging Research) to The Pennsylvania State University (Penn State) to develop and test novel interventions for improving adherence to behavior change and enhancing cognitive function in middle-aged and older adults. The key products and services to be delivered under this 5-year grant include: 1) Conducting three clinical trials to develop scalable, principle-driven behavioral interventions that engage targeted...
This $1,548,995 federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will support research at The Pennsylvania State University to elucidate the cognitive and neural mechanisms underlying the benefits of environmental support on associative memory in younger and older adults. The research aims to identify effective approaches for enhancing associative memory function in the aging population, a critical issue given the projected growth of the U.S....
This $243,000 federal Project Grant award from the National Institute on Aging (under CFDA 93.866 - Aging Research) aims to develop an intervention for deprescribing potentially inappropriate medications (PIMs) among older adults with Alzheimer's disease and related dementias (ADRD) receiving home health care services. The 5-year project has two key objectives: 1) to identify factors associated with and barriers/facilitators of routine PIM deprescribing for ADRD patients in home health care,...
This $232,719 federal Project Grant award, supported by the National Institute on Aging's Aging Research program (CFDA 93.866), aims to develop the IMPRINT program - an innovative educational initiative focused on Alzheimer's disease and related dementias (ADRD). The IMPRINT program will provide a one-year, hybrid training model to a cohort of 12-15 graduate students and postdocs. The program combines immersive, patient-centric experiences with entrepreneurship training to foster the development...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $460,388 to The Pennsylvania State University to pilot test the "Promoting Positive Care Interactions (PPCI)" intervention. The goal is to establish a feasible and culturally responsive approach to optimize care interactions between staff (nursing, activity, housekeeping, and dining service) and residents with Alzheimer's disease and related dementias (ADRD) in assisted living facilities (ALFs). The project aims to examine the feasibility and acceptability of PPCI, as well as test its preliminary efficacy on select resident, staff, and organizational outcomes related to quality of life, agitation, resistiveness to care, quality of care interactions, staff knowledge/competence, and facility environment/policies. The study will run from September 2024 to August 2026.